PBYI
PBYI
NASDAQ · Biotechnology

Puma Biotechnology Inc

$7.35
-0.18 (-2.39%)
As of May 9, 1:53 AM ET ·
Analyst Consensus
Strong Sell
6
Analysts
Moderate
Coverage
Buy 0 0%
Hold 3 50%
Sell 3 50%
Price Target
Analyst Price Target -25.9% upside
Low Target $2.99
Average Target $5.45
High Target $6.80
Current Price $7.35
Current
$7.35
Target
$5.45
$2.99 $5.45 avg $6.80
Scenario Analysis
Bear Case
$2.99
-59.3%
Low target
Base Case
$5.45
-25.9%
Avg target
Bull Case
$6.80
+-7.5%
High target
Risk/Reward
0.1x
Unfavorable
Price in Context
52-Week High
$7.90
-6.9% from high
52-Week Low
$2.85
+157.9% from low
Target vs 52W High
$5.45
-31.0% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 40 75% $257.58 +27.8%
AMGN
Amgen Inc
Hold 44 48% $190.87 -42.5%
GILD
Gilead Sciences Inc
Strong Buy 39 79% $362.68 +176.2%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 79% $438.34 +2.0%
REGN
Regeneron Pharmaceuticals
Strong Buy 38 79% $76.80 -89.3%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 75% $102.31 -65.3%
RVMD
Revolution Medicines Inc
Strong Buy 27 96% $114.11 -19.5%
INSM
Insmed Inc
Strong Buy 28 96% $143.40 +41.5%